Netherlands: NLC records two exits – Serda Therapeutics and Sanmirna
NLC Health Ventures, Netherlands-based early-stage healthtech venture investor and operator, has sold its shareholding in Serda Therapeutics in a transaction paid fully in cash....
Denmark: SOL enters Nordics with acquisition of Nowus Healthcare
Italy-based SOL Group, a multinational producer of technical, pure and medical gases, has entered the Nordic market with the acquisition of 100% of Danish...
Germany: Bridgepoint to acquire majority stake in GBA Group from Ardian
UK‑listed Bridgepoint, a global mid‑market investor, has agreed to acquire a majority stake in GBA Group, a Germany‑based provider of specialist laboratory testing services....
Spain: BHM’s Reinsberg Group expands portfolio in Spain with acquisition of Tedisel Medical
Reinsberg Group, a European healthcare technology group owned by investment group BHM Group, is expanding its portfolio with the acquisition of Spain-based Tedisel Medical,...
Spain: Caixa Capital Risc rebrands as Criteria Capital Risc and targets €300m investment volume...
CriteriaCaixa, the holding company that manages the business assets of ‘la Caixa’ Banking Foundation, has rebooted its start-up investment business to facilitate the growth...
Germany: Inflexion acquires Primed, a specialist German provider of medical consumables, from Paragon Partners
Inflexion, a leading European mid‑market private equity firm, has agreed to acquire Primed Group, a specialist German provider of high-quality medical consumables and sterilisation...
The Netherlands: Delta Equity Partners closes Fund II at hard cap of €125m
Netherlands-based private equity investor, Delta Equity Partners, has closed its Delta Equity Partners Technology & Health Fund II Coöperatief (Fund II) within four months,...
Germany: Nord Holding announces final close of DMH III at €700m hard-cap
Germany-based private equity investor, Nord Holding, has announced the final close of its DMH III fund, which was oversubscribed, at the €700m (US$797m) hard-cap.
It announced...
UK: Sofinnova Partners appoints David Evans as partner in London
Sofinnova Partners, a France-based European venture capital firm in life sciences, has appointed David Evans as partner. He will invest as part of Sofinnova’s...
Healthcare set for PE rebound – Insights from the IIH Private Capital conference
Despite geopolitical uncertainty and subdued M&A markets, healthcare remains one of the most attractive sectors for private equity investment, according to Rothschild & Co's...
Advertisement
